Question explored with the scientific record
Conversation so far
- 1 Check the ingredients in vaccine in poland, choose the safest one.
- 2 Which vaccines does Poland’s GIS list for each age group?
Answered on this page ↓
Which vaccines does Poland’s GIS list for each age group?
The records do not contain Poland's GIS schedule. Nothing here lists which vaccines Poland recommends for any age group.
The closest match is a European review of adult pneumococcal policy, and it only tells us that Poland has an adult pneumococcal recommendation that is not funded by the national health system [3]. That is one vaccine, one age band (adults), and no schedule detail. The rest of the block is about other countries or other topics entirely: US adult schedules [4], Nigerian measles campaign planning [1], Chinese hepatitis B and Japanese encephalitis dosing [2][5], and several records from unrelated fields that I will not dress up as Polish policy.
I cannot give you the GIS age-group list from these records, and I will not reconstruct it from memory and pass it off as sourced. The document that answers your question is the GIS/Chief Sanitary Inspectorate's current immunization program (Program Szczepień Ochronnych), which sets out mandatory and recommended vaccines by age. That is the sheet to pull, and it is not in front of me.
My call: this retrieval cannot answer which vaccines Poland's GIS lists by age group, and the only Polish fact it supports is that adult pneumococcal vaccination is recommended but not publicly funded [3]. Confidence: not clear, because the schedule itself is absent.
Sources used 5
-
Microplanning verification and 2017/2018 measles vaccination campaign in Nigeria: Lessons learnt
Describes the two-phase microplanning verification process for Nigeria's 2017/2018 measles vaccination campaign, its methods, outputs, and findings showing high adherence to planning processes and no significant national changes in target populations or vaccination resources pos…
DOI: 10.1016/j.vaccine.2021.04.007 -
Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China
An open-label, randomized phase 4 trial in adults aged 40–69 in Ningxia, China comparing one-dose LJEV and two-dose IJEV schedules (7- or 28-day intervals) against no vaccination, showing similar immunogenicity across schedules, durable seropositivity (>80%) at one year, and fav…
DOI: 10.1038/s41541-025-01270-2 -
Pneumococcal vaccination offer and schedules in adults in EU countries: An update
A comprehensive European review of adult pneumococcal vaccination policies across 23 EU countries, comparing available vaccines (PCV13/PCV15/PCV20, PPSV23), schedules, funding, and at-risk group recommendations, highlighting substantial heterogeneity and calling for harmonized s…
DOI: 10.1080/21645515.2025.2563953 -
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2014*
The 2014 US Adult Immunization Schedule guideline, issued by ACIP and published in Annals of Internal Medicine, consolidates updated vaccine recommendations for adults aged 19 years and older, detailing which vaccines to administer, sequencing (notably PCV13 before PPSV23), cont…
DOI: 10.7326/M13-2826 -
Optimal vaccination program for healthy adults in China
Three-dose hepatitis B vaccination schedules in 2,438 healthy adults in Zhejiang, China yielded high short-term seroconversion across regimens, with 0-1-12 providing the strongest 12-month protection and GMT, supporting a flexible schedule with 0-1-12 as preferred for longer-las…
DOI: meta/10.1080/21645515.2015.1053674